SA's vaccine manufacturing capability has received another boost as local biopharmaceutical company Biovac becomes part of an international agreement to produce an oral cholera vaccine that will benefit
mostly African countries...You’ve always trusted us to help you navigate the world. Support the Sunday Times by becoming a premium member for only R80 and keep the conversation going. You can cancel anytime.
Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más: